We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$225M
O
2
OrbiMed
New York
$89.6M
RCM
3
RA Capital Management
Massachusetts
$83.6M
VVA
4
Vida Ventures Advisors
Massachusetts
$64M
Fidelity Investments
5
Fidelity Investments
Massachusetts
$49M -$677K -26,627 -1%
Viking Global Investors
6
Viking Global Investors
Connecticut
$42.4M -$1.31M -51,561 -3%
VA
7
VR Adviser
New York
$34.3M
LGM
8
Logos Global Management
California
$31M +$10.1M +395,000 +42%
Citadel Advisors
9
Citadel Advisors
Florida
$30.3M -$376K -14,763 -1%
BlackRock
10
BlackRock
New York
$29.6M +$1.61M +63,331 +5%
Vanguard Group
11
Vanguard Group
Pennsylvania
$27.7M -$2.98M -117,091 -9%
BC
12
Boxer Capital
California
$24.8M
DM
13
Deerfield Management
New York
$23.7M +$17.2M +675,000 +196%
FCMV
14
Foresite Capital Management V
California
$20.4M
Janus Henderson Group
15
Janus Henderson Group
$13.5M -$5.03M -197,538 -25%
HMC
16
Harvard Management Company
Massachusetts
$11.6M
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$10.4M -$5.17M -203,305 -31%
RSCM
18
Rock Springs Capital Management
Maryland
$7.72M +$132K +5,200 +2%
Federated Hermes
19
Federated Hermes
Pennsylvania
$7.17M
NHAS
20
Novo Holdings A/S
Denmark
$6.98M
PHS
21
PFM Health Sciences
California
$6.15M
WP
22
Woodline Partners
California
$6.06M -$658K -25,853 -9%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$5.52M -$33.9K -1,332 -0.6%
State Street
24
State Street
Massachusetts
$5.52M +$1.37M +53,848 +29%
Franklin Resources
25
Franklin Resources
California
$4.47M +$435K +17,093 +10%